US Patent Issued to IMMATICS BIOTECHNOLOGIES on May 13 for "Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers" (German Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,295,995, issued on May 13, was assigned to IMMATICS BIOTECHNOLOGIES GMBH (Tubingen, Germany).

"Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers" was invented by Toni Weinschenk (Tuebingen, Germany), Jens Fritsche (Tuebingen, Germany), Harpreet Singh (Tuebingen, Germany), Andrea Mahr (Tuebingen, Germany), Martina Ott (Tuebingen, Germany), Claudia Wagner (Tuebingen, Germany) and Oliver Schoor (Tuebingen, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present i...